Most bacterial infections can be treated with antibiotics such as penicillin, discovered decades ago. However, such drugs are useless against viral infections, including influenza, the common cold, and deadly hemorrhagic ...
Aug 10, 2011
69
0
With much of the world still susceptible to SARS-CoV-2, experts predict the virus will become endemic.
Aug 13, 2021
0
79
Researchers from the Medway School of Pharmacy (a partnership between the universities of Kent and Greenwich) have helped isolate the Lloviu virus (LLOV)—a close relative of Ebola virus—for the first time, highlighting ...
May 6, 2022
0
211
Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible ...
Aug 21, 2020
0
720
The news about remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19, keeps getting better.
Jul 9, 2020
0
1392
Infectious disease scientists report early development of a potential universal vaccine for Ebola viruses that preclinical tests show might neutralize all four species of these deadly viruses infecting people in recent outbreaks, ...
Apr 16, 2020
0
1849
A team of international researchers has discovered a new Ebola-like virus – Lloviu virus -- in bats from northern Spain. Lloviu virus is the first known filovirus native to Europe, they report in a study published in ...
Oct 21, 2011
0
0
After analyzing the blood of a survivor of the 2013-16 Ebola outbreak, a team of scientists from academia, industry and the government has discovered the first natural human antibodies that can neutralize and protect animals ...
May 18, 2017
0
2180
The global death toll from COVID-19, which is set to pass five million, is already far worse than most other viral epidemics of the 20th and 21st centuries.
Nov 1, 2021
0
13
There is a new medication that in one dose successfully protected nonhuman primates against a lethal infection of all strains of the deadly Ebola virus. The findings are now available in Cell Host & Microbe.
Jan 9, 2019
0
7055
Ivory Coast ebolavirus Reston ebolavirus Sudan ebolavirus
Ebola is the common term for a group of viruses belonging to genus Ebolavirus (EBOV), which is a part of the family Filoviridae, and for the disease that they cause, Ebola hemorrhagic fever. The virus is named after the Ebola River, where the first recognized outbreak of Ebola hemorrhagic fever occurred. The viruses are characterized by long filaments, and have a shape similar to that of the Marburg virus, also in the family Filoviridae, and possessing similar disease symptoms.
There are a number of species within the ebolavirus genus, which in turn have a number of specific strains or serotypes. The Zaïre virus is the type species, which is also the first discovered and the most lethal. Ebola is transmitted primarily through bodily fluids and to a limited extent through skin and mucous membrane contact. The virus interferes with the endothelial cells lining the interior surface of blood vessels and platelet cells. As the blood vessel walls become damaged and the platelets are unable to coagulate, patients succumb to hypovolemic shock.
Ebola first emerged in 1976 in Zaire. It remained largely obscure until 1989 with a widely publicized outbreak in Reston, Virginia.
This text uses material from Wikipedia, licensed under CC BY-SA
